Vision Disorders Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
- Transparency Market Research
Although there are significant progress in preventing and curing visual impairment in many countries since last twenty years, according to World Health Organization (WHO) around 285 million (In the year 2013) people are still visually impaired across the world. It is a matter of great concern. The reasons may be varied. However, we cannot deny the fact that there is still a lot to be done to save the people from going blind.
Any disturbance in the normal sense of vision can be termed as vision disorders. Myopia, hyperopia, astigmatism, presbyopia, conjunctivitis, cataract, corneal abrasion, entropion and glaucoma are some of the vision disorders, affecting majority of the population across the world. Improper nutrition, various infections, traumatic eye injury, insertion of foreign objects and growing age are major causes for majority of the vision disorders.
Vision disorders: Control and prevention
According WHO, 80 percent of visually impaired people can be cured by using simple eye examinations like abnormality in a frequency of blinking, size of pupil and color of the eye. The disorders can be confirmed by suitable clinical and retinal tests such as corneal topography, keratometry, pachymetry, fluorescein angiography, Indocyanine Green study (ICG) dye test and other related tests. However, ignorance and negligence are leading severe eye complications or permanent vision loss.
The report published by Centers for Disease Control and Prevention (CDC), revealed that approximately 14 million Americans above age of twelve are affected by various vision disorders in 2004. All these reports are alarming towards the need of immediate treatment for vision disorders across the world. This precisely a reason that the market for visual disorders may continue to grow in future.
There are many companies which are involved in extensive research and development activities associated with these disorders such as United States based National Eye Institute working on clinical trials for nutritional supplements for age related cataract. Alcon Research is working on small incision cataract surgery. AqueSys, Inc. evaluating safety of AqueSys XEN 45 glaucoma implant in refractory glaucoma. Apart from this, University of Pennsylvania in collaboration with local NGOs is working on ancillary therapy of different eye infections.
In case of region wise achievements in fighting against the visual disorders, Brazil has been providing eye care service through the national social security system since last decade. While, Morocco has launched a public effort to control glaucoma, China has invested over 100 million dollars in cataract surgeries since 2009. Oman has completely integrated eye care service provision in the primary health care framework over the last decade and India since 1995 has made available funds for eye care service provision for the poorest at district level.
To reduce the burden of chronic eye diseases WHO is also coordinating a global research efforts to map services and policies for controlling diabetic retinopathy, glaucoma, age related macular degeneration and refractive errors. To support comprehensive eye care systems, WHO continues to provide epidemiologic and public health technical support to its member states.
Vision Disorders Market Segmentation
Coming towards market point of view, the market for vision disorders can be segmented according to different perspectives such as regional geography and types of disorder. It can be segmented in four regions namely North American, Europe, Asia-Pacific and Rest of the World. Out of all these segments North America region have highest contribution in terms of value because of large number of population within the reach of treatment, high awareness and better reimbursement policies.
Followed by this Europe, Asia-Pacific and Rest of the World respectively are major segments of the market. The market can also be segmented among disorders such as cataract, glaucoma, eye infections and refractive errors. Along with this, the market for visual disorders can be categorized into drugs and devices available for the treatment.
Currently various established pharmaceutical and biotechnology companies are catering the needs of visual disorders by providing drugs and lenses. Pfizer, Alcon, Novartis, Johnson & Johnson, Hoffmann-La Roche Ltd. and GlaxoSmithKline are leading contributors in drug therapy, while Novartis and Bausch & Lomb are major players in lenses.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017